JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC
What was lobbied
10 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
HR 1908, “Patent Reform Act of 2007,” regarding amending title 35, United States Code, to provide for patent reform; Thailand Compulsory License.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | N/A |
| JEREMY ALLEN | N/A |
| TAMMY BOYD | N/A |
| BRIAN BURNS | N/A |
| CATHLEEN DOOLEY | N/A |
| DARREL C JODREY | N/A |
| CAROLINE MOODY SCHELLHAS | N/A |
| CHARLES NAU | N/A |
| SUSAN REARDON | N/A |
| SHANNON SALMON | N/A |
Defense DEF
HR 1591, “U.S. Troop Readiness, Veterans' Health, and Iraq Accountability Appropriations Act, 2007,” regarding medicaid rebates.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | N/A |
| JEREMY ALLEN | N/A |
| TAMMY BOYD | N/A |
| BRIAN BURNS | N/A |
| CATHLEEN DOOLEY | N/A |
| DARREL C JODREY | N/A |
| CAROLINE MOODY SCHELLHAS | N/A |
| CHARLES NAU | N/A |
| SUSAN REARDON | N/A |
| SHANNON SALMON | N/A |
Taxation/Internal Revenue Code TAX
S 41, “Research Competitiveness Act of 2007,” regarding amending the Internal Revenue Code of 1986 to provide incentives to improve America's research competitiveness. HR 1712, “Research and Development Tax Credit Act of 2007,” regarding amending the Internal Revenue Code of 1986 to provide incentives to improve America's research competitiveness; HR 763, “To amend the Internal Revenue Code of 1986 to make permanent the deduction allowable with respect to income attributable to domestic production activities in Puerto Rico,” all provisions;
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | N/A |
| JEREMY ALLEN | N/A |
| TAMMY BOYD | N/A |
| BRIAN BURNS | N/A |
| CATHLEEN DOOLEY | N/A |
| DARREL C JODREY | N/A |
| CAROLINE MOODY SCHELLHAS | N/A |
| CHARLES NAU | N/A |
| SUSAN REARDON | N/A |
| SHANNON SALMON | N/A |
Trade (domestic/foreign) TRD
Issues regarding bilateral free trade agreements with South Korea, Peru, Columbia and Panama.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | N/A |
| JEREMY ALLEN | N/A |
| TAMMY BOYD | N/A |
| BRIAN BURNS | N/A |
| CATHLEEN DOOLEY | N/A |
| DARREL C JODREY | N/A |
| CAROLINE MOODY SCHELLHAS | N/A |
| CHARLES NAU | N/A |
| SUSAN REARDON | N/A |
| SHANNON SALMON | N/A |
Health Issues HCR
HR 1424, "Paul Wellstone Mental Health and Addiction Equity Act of 2007,” regarding amending section 712 of the Employee Retirement Income Security Act of 1974, section 2705 of the Public Health Service Act, and section 9812 of the Internal Revenue Code of 1986 to require equity in the provision of mental health and substance-related disorder benefits under group health plans; HR 1494 / S 830, “Pediatric Medical Device Safety and Improvement Act of 2007,” regarding improving the process for the development of needed pediatric medical devices; HR 1956, “Patient Protection and Innovative Biologic Medicines Act of 2007,” regarding amending the Public Health Service Act to provide for the approval of similar biological products; HR 2193, “Animal Protection Accountability Improvement Act,” regarding amending the Animal Welfare Act to increase the penalties for violations of such Act and to prohibit the use of animals for marketing medical devices; HR 2349 / S 1413, “Uterine Fibroid Research and Education Act of 2007,” regarding providing for research and education with respect to uterine fibroids; HR 3333 / S. 1576, “Minority Health Improvement and Health Disparity Elimination Act,” regarding amending the Public Health Service Act to improve the health and healthcare of racial and ethnic minority groups; HR 788 / S 468, “Food and Drug Administration Safety Act of 2007,” regarding amending the Federal Food, Drug, and Cosmetic Act with respect to drug safety; HR 2900, “Food and Drug Administration Amendments Act of 2007,” regarding amending the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices and to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs; S 1082, “Food and Drug Administration Revitalization Act,” regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize drug and device user fees and ensure the safety of medical products; S 1695, “Biologics Price Competition and Innovation Act of 2007,” regarding amending the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products and to promote innovation in the life sciences; S 467, “Fair Access to Clinical Trials Act of 2007 or the `FACT Act',” regarding amending the Public Health Service Act to expand the clinical trials drug data bank; S 558, “Mental Health Parity Act of 2007,” regarding all provisions; S 628, “Critical Access to Health Information Technology Act of 2007,” regarding providing grants for rural health information technology development activities; S 993, “Pediatric Research Improvement Act,” regarding improving pediatric research; issues regarding Acetemorphine and Phenelyperine. HR 1165, “Swift Approval, Full Evaluation Drug Act or the `SAFE Drug Act',” regarding amending the Federal Food, Drug, and Cosmetic Act to establish additional authorities to ensure the safe and effective use of drugs and to establish whistleblower protections for certain individuals;
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | N/A |
| JEREMY ALLEN | N/A |
| TAMMY BOYD | N/A |
| BRIAN BURNS | N/A |
| CATHLEEN DOOLEY | N/A |
| DARREL C JODREY | N/A |
| CAROLINE MOODY SCHELLHAS | N/A |
| CHARLES NAU | N/A |
| SUSAN REARDON | N/A |
| SHANNON SALMON | N/A |
Medicare/Medicaid MMM
HR 1663, “Medicare Mental Health Modernization Act of 2007,” regarding amending title XVIII of the Social Security Act to expand and improve coverage of mental health services under the Medicare Program; HR 1845 / S 1428, “Medicare Durable Medical Equipment Access Act of 2007,” regarding amending part B of title XVIII of the Social Security Act to assure access to durable medical equipment under the Medicare Program; HR 2770, “To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price,” all provisions; HR 3011, “To amend title XVIII of the Social Security Act to ensure adequate payment amounts for drugs and biologicals under part B of the Medicare Program,” regarding all provisions; HR 3061, “Medicare Part D Drug Class Protection Act of 2007,” regarding amending title XVIII of the Social Security Act to require that Medicare prescription drug plans using formularies cover all drugs included in 6 specified therapeutic categories and to establish protective requirements for coverage determinations; HR 4 / S 3, “Medicare Prescription Drug Price Negotiation Act of 2007,” regarding amending part D of title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate lower covered part D drug prices on behalf of Medicare beneficiaries; HR 976 / S 1893, “Children's Health Insurance Program Reauthorization Act of 2007,” regarding amending the Internal Revenue Code of 1986 to provide tax relief for small businesses; HR 3162, “Children's Health and Medicare Protection Act of 2007,” regarding improving enrollment and retention of eligible children; S 1887, “Medicare Access to Critical Medications Act of 2007,” regarding amending title XVIII of the Social Security Act in order to ensure access to critical medications under the Medicare part D prescription drug program; S 631, “Remote Monitoring Access Act of 2007,” regarding amending title XVIII of the Social Security Act to provide for coverage of remote patient management services for chronic health care conditions under the Medicare Program; S 860, “Early Treatment for HIV Act of 2007,” regarding amending title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV; CMS-1270-F, “Medicare Program; Competitive Acquisition for Certain Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) and Other Issues,” regarding a final rule establishing competitive bidding programs for certain Medicare Part B covered items of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) throughout the United States in accordance with sections 1847(a) and (b) of the Social Security Act; issues regarding competitive bidding, demonstrations for clinical lab services and competitive Medicare payments for lab services; issues regarding Medicare national coverage determination for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions; CMS-2238-FC, regarding the Medicaid program, and prescription drugs. HR 1190, “Community Cancer Care Preservation Act of 2007,” regarding amending title XVIII of the Social Security Act to preserve access to community cancer care by Medicare beneficiaries; HR 1321, “Medicare Advanced Laboratory Diagnostics Act of 2007,” regarding amending title XVIII of the Social Security Act to improve payments under the Medicare clinical laboratory fee schedule;
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | N/A |
| JEREMY ALLEN | N/A |
| TAMMY BOYD | N/A |
| BRIAN BURNS | N/A |
| CATHLEEN DOOLEY | N/A |
| DARREL C JODREY | N/A |
| CAROLINE MOODY SCHELLHAS | N/A |
| CHARLES NAU | N/A |
| SUSAN REARDON | N/A |
| SHANNON SALMON | N/A |
Budget/Appropriations BUD
H Con Res 99, "Revising the congressional budget for the United States Government for fiscal year 2007, establishing the congressional budget for the United States Government for fiscal year 2008, and setting forth appropriate budgetary levels for fiscal years 2009 through 2012," regarding healthcare funding issues. HR 3043 / S 1710, “Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008,” regarding appropriations; HR 3161 / S 1859, “Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008,” regarding drug importation;
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | N/A |
| JEREMY ALLEN | N/A |
| TAMMY BOYD | N/A |
| BRIAN BURNS | N/A |
| CATHLEEN DOOLEY | N/A |
| DARREL C JODREY | N/A |
| CAROLINE MOODY SCHELLHAS | N/A |
| CHARLES NAU | N/A |
| SUSAN REARDON | N/A |
| SHANNON SALMON | N/A |
Pharmacy PHA
S 242, “Pharmaceutical Market Access and Drug Safety Act of 2007,” regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs; S 251, “Pharmaceutical Market Access Act of 2007,” regarding amending the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs. HR 2589, “Improving Pharmaceuticals for Children Act of 2007,” regarding amending the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to reauthorize and amend the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act; S 1156, “Best Pharmaceuticals for Children Amendments of 2007,” regarding amending the Federal Food, Drug, and Cosmetic Act to reauthorize the Best Pharmaceuticals for Children program;
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | N/A |
| JEREMY ALLEN | N/A |
| TAMMY BOYD | N/A |
| BRIAN BURNS | N/A |
| CATHLEEN DOOLEY | N/A |
| DARREL C JODREY | N/A |
| CAROLINE MOODY SCHELLHAS | N/A |
| CHARLES NAU | N/A |
| SUSAN REARDON | N/A |
| SHANNON SALMON | N/A |
Medical/Disease Research/Clinical Labs MED
HR 2762 / S 1494, “To amend the Public Health Service Act to reauthorize the special diabetes programs for Type I diabetes and Indians under that Act,” all provisions; S 976, "Genomics and Personalized Medicine Act of 2007," all provisions; S 736, "Laboratory Test Improvement Act," all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | N/A |
| JEREMY ALLEN | N/A |
| TAMMY BOYD | N/A |
| BRIAN BURNS | N/A |
| CATHLEEN DOOLEY | N/A |
| DARREL C JODREY | N/A |
| CAROLINE MOODY SCHELLHAS | N/A |
| CHARLES NAU | N/A |
| SUSAN REARDON | N/A |
| SHANNON SALMON | N/A |
Law Enforcement/Crime/Criminal Justice LAW
S 635, “Methamphetamine Remediation Research Act of 2007,” regarding providing for a research program for remediation of closed methamphetamine production laboratories; issues regarding Federal judicial salaries.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | N/A |
| JEREMY ALLEN | N/A |
| TAMMY BOYD | N/A |
| BRIAN BURNS | N/A |
| CATHLEEN DOOLEY | N/A |
| DARREL C JODREY | N/A |
| CAROLINE MOODY SCHELLHAS | N/A |
| CHARLES NAU | N/A |
| SUSAN REARDON | N/A |
| SHANNON SALMON | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.